Viking Therapeutics VKTX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's accounts payable?
- Viking Therapeutics (VKTX) reported accounts payable of $67.18M in Q1 2026.
- How has Viking Therapeutics's accounts payable changed year-over-year?
- Viking Therapeutics's accounts payable increased by 772.3% year-over-year, from $7.7M to $67.18M.
- What is the long-term trend for Viking Therapeutics's accounts payable?
- Over 5 years (2020 to 2025), Viking Therapeutics's accounts payable has grown at a 67.9% compound annual growth rate (CAGR), from $3.99M to $53.25M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.